Defects in the activity of AMPK ultimately lead to upregulation of several immune-suppressive proteins like programmed cell death 1 (PD-1), which restricts immunological responses, upholds peripheral tolerance, and aids in tumor growth [31]. This evidence concerns the gene PDCD1 and neoplasm.